BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
104 hedge funds and large institutions have $742M invested in bluebird bio in 2014 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
+21
Holders Change %
+25.3%
% of All Funds
2.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
34
Reduced
21
Closed
19
Calls
$6.52M
Puts
$2.68M
Net Calls
+$3.84M
Net Calls Change
+$3.91M
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$41.5M |
2 |
2
Goldman Sachs
New York
|
$12.2M |
3 |
BFA
3
BlackRock Fund Advisors
San Francisco,
California
|
$29.3M |
4 |
PC
4
PointState Capital
New York
|
$10.6M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$15.5M |